| Literature DB >> 33378673 |
Eva Hulstaert1, Annelien Morlion2, Francisco Avila Cobos2, Kimberly Verniers2, Justine Nuytens2, Eveline Vanden Eynde2, Nurten Yigit2, Jasper Anckaert2, Anja Geerts3, Pieter Hindryckx3, Peggy Jacques4, Guy Brusselle5, Ken R Bracke5, Tania Maes5, Thomas Malfait5, Thierry Derveaux6, Virginie Ninclaus6, Caroline Van Cauwenbergh6, Kristien Roelens7, Ellen Roets7, Dimitri Hemelsoet8, Kelly Tilleman9, Lieve Brochez10, Scott Kuersten11, Lukas M Simon12, Sebastian Karg13, Alexandra Kautzky-Willers14, Michael Leutner14, Christa Nöhammer15, Ondrej Slaby16, Roméo Willinge Prins17, Jan Koster17, Steve Lefever2, Gary P Schroth11, Jo Vandesompele2, Pieter Mestdagh18.
Abstract
Extracellular RNAs present in biofluids have emerged as potential biomarkers for disease. Where most studies focus on blood-derived fluids, other biofluids may be more informative. We present an atlas of messenger, circular, and small RNA transcriptomes of a comprehensive collection of 20 human biofluids. By means of synthetic spike-in controls, we compare RNA content across biofluids, revealing a 10,000-fold difference in concentration. The circular RNA fraction is increased in most biofluids compared to tissues. Each biofluid transcriptome is enriched for RNA molecules derived from specific tissues and cell types. Our atlas enables an informed selection of the most relevant biofluid to monitor particular diseases. To verify the biomarker potential in these biofluids, four validation cohorts representing a broad spectrum of diseases were profiled, revealing numerous differential RNAs between case and control subjects. Spike-normalized data are publicly available in the R2 web portal for further exploration.Entities:
Keywords: RNA sequencing; biofluids; biomarker; cell-free RNA; circular RNA; extracellular RNA; liquid biopsy; messenger RNA; small RNA
Year: 2020 PMID: 33378673 DOI: 10.1016/j.celrep.2020.108552
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423